Disclosure 0001395064-26-000335-1

SEC FORM 4

$2,148,371.59

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 116,191 shares at $18.49 per share.

Reporting Person Plump Andrew Stewart · Officer Title President, R&D · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001395064-26-000335 · filed 2026-09-03 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "TAKEDA PHARMACEUTICAL CO LTD (TAK)." Disclosed 2026-09-03. https://desqlong.com/cards/0001395064-26-000335-1 (retrieved 2026-09-26).